ARPA-H picks UpDoc, Tempus and Atman to build AI tools for heart disease

Positive

AI Analysis

Summary

ARPA-H announced that UpDoc, Tempus AI, and Atman Health have been selected to develop FDA-authorized agentic AI tools for heart disease care through the ADVOCATE program.

Outcome Details

ARPA-H selected UpDoc, Tempus AI, and Atman Health to participate in ADVOCATE program to build FDA-authorized agentic AI tools for heart disease care

Importance:5/10

Sentiment:

0.60

AIheart diseaseFDA authorizationARPA-Hpartnership

Related Companies

$TEM

Read the original article

Published by Endpoints News on September 9, 2026 5:44 PM

Read Original